Since it works on both GLP-1 and GIP receptors, it offers dual action, reducing appetite, slowing digestion, and improving insulin sensitivity
doi.org/10.1016/j.molcel.2015.01.034 Verdin, E
Marilynn Larkin, MA, is an award-winning medical writer and editor whose work has appeared in numerous publications, including Medscape Medical News and its sister publication MDedge, The Lancet (where she was a contributing editor), and Reuters Health.
However, there is an important detail people should understand: There have not yet been large direct head-to-head trials comparing retatrutide and tirzepatide under identical conditions
At the same time, some users have responded by sharing studies and data showing that such side effects are uncommon
They can also help with conditions associated with obesity, such as: Cancer : People with obesity have an increased risk of some types of cancer